FlyteHealth Announces Executive Leadership Expansion Amidst Continued Growth

NEW CANAAN, Conn., Aug. 12, 2025 /PRNewswire/ — FlyteHealth, a leader in cardiometabolic care, today announced the appointment of Dr. Cheryl Pegus as Chief Executive Officer and Board Chair. Sloan Saunders, FlyteHealth’s founding CEO, transitions to the role of President, working closely with Dr. Pegus. This leadership expansion reflects FlyteHealth’s strong market trajectory and positions the company for its next stage of scaled impact across the employer, payor, and health system landscape.

Dr. Pegus, previously Executive Chair of FlyteHealth, brings over 30 years of clinical, operational, and strategic expertise across the healthcare continuum. Since joining FlyteHealth, she has been instrumental in accelerating execution, driving product innovation, and expanding reach. Her appointment as CEO continues FlyteHealth’s commitment to an outcomes-driven approach and a reinforced focus on cardiometabolic care and whole health.

“Under the founders of FlyteHealth and the exceptional leadership of Sloan, we are positioned to address the needs of patients, support the team providing care, and build upon our strong foundation of proven success in cost-effective, engaged care. I look forward to continuing the work with this team,” said Dr. Cheryl Pegus.

As President, Sloan Saunders will continue to play a critical role in advancing FlyteHealth’s strategic vision. A founder and visionary behind the company’s growth, Saunders will focus on scaling partnerships, supporting operational execution, and working closely with Dr. Pegus to deliver long-term impact.

“From the beginning, we believed that healthcare could be fundamentally transformed by combining scalable technology with deeply human-centered care,” said Saunders. “I’m excited to build on what we’ve started, together with Cheryl and the exceptional team at FlyteHealth.”

Expanding Executive Leadership

In addition to this executive transition, FlyteHealth is expanding its leadership team with experienced operators from across the healthcare ecosystem:

• Cheryl Pegus, MD, MPH, Chief Executive Officer, Board Chair – Dr. Pegus brings over 30 years of clinical and business leadership across the healthcare sector. She has held executive roles across healthcare delivery and solution services companies, focusing on company growth and bringing innovative solutions to market for healthcare professionals and patients, targeting healthcare outcomes alongside financial sustainability. She currently serves on the boards of public and private companies, the non-profit boards of the American Heart Association and the Alice Walton School of Medicine, and co-chairs the Duke Margolis Capital Impact Council. A cardiologist by training, she is also a cookbook author.
• Ishraf Ahmad, Chief Product and Technology Officer – Ishraf brings more than 15 years of healthcare technology leadership, developing and scaling digital products across the payor, provider, and consumer landscape. He has held senior product leadership roles at Virta Health and UnitedHealth Group, where he launched AI-driven care tools, clinical platforms, and enterprise solutions used by millions of patients. Known for combining strategic vision with deep user empathy, Ishraf builds high-performing teams that deliver measurable impact and advance equitable, behavior-driven care.
• Melanie Curtice, General Counsel – Melanie brings more than 20 years of experience in healthcare regulatory, benefits, transactional, and governance matters, with deep expertise supporting organizations that serve payors and employers. She previously served as General Counsel and Corporate Secretary at 98point6 and was a partner at Perkins Coie and Stoel Rives. Recognized as “Lawyer of the Year” in Employee Benefits Law by Best Lawyers Magazine, Melanie is known for her strategic and practical legal guidance.
• Beth Baker, FSA, MAAA, Senior Director of Actuarial Services – Beth brings over 25 years of experience in actuarial science and healthcare, specializing in strategic financial analysis, innovative reimbursement models, and operational excellence for insurers, providers, and regulators. A Fellow of the Society of Actuaries and Member of the American Academy of Actuaries, she actively contributes to the profession through research and presentations on AI in healthcare.

These leadership additions underscore FlyteHealth’s ambition to lead the next era of virtual cardiometabolic care delivery with clinical integrity, operational excellence, and measurable outcomes at the core.

About FlyteHealth

FlyteHealth delivers a precision cardiometabolic care solution spanning obesity, diabetes, hypertension, hyperlipidemia, and related comorbidities using data and AI enablement for proven, cost-effective, and scalable treatment models nationwide. FlyteHealth was founded by leaders in clinical obesity management and was built on a foundation of robust data and years of hands-on clinical expertise. FlyteHealth’s offering combines AI-powered clinical intelligence with smart technology and decision support tools that translate complex evidence into seamless care delivery with methodologies built for real-world speed. FlyteHealth focuses on close customer partnership, improving measurable outcomes, and every aspect of its model is designed for cost-effectiveness, optimizing savings while driving better engagement and patient adherence. Learn more at www.flytehealth.com.

For inquiries, please contact: liz.joyce@flytehealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/flytehealth-announces-executive-leadership-expansion-amidst-continued-growth-302527305.html

SOURCE FlyteHealth